K-V PHARMACEUTICAL 'HOLD,' TARGET PRICE REDUCED

A A

Analysts at Deutsche Bank Securities maintain their "hold" rating on K-V Pharmaceutical. The target price has been reduced from $26 to $20.
Newratings